These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34678217)

  • 41. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
    Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
    J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients.
    Chen L; Ma H; Hu H; Gao L; Wang X; Ma J; Gao Q; Liu B; Zhou G; Liang C
    BMC Cancer; 2014 Jul; 14():489. PubMed ID: 25000974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion.
    Jiang R; Tang J; Chen Y; Deng L; Ji J; Xie Y; Wang K; Jia W; Chu WM; Sun B
    Nat Commun; 2017 May; 8():15129. PubMed ID: 28541302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.
    Ho C; Wang C; Mattu S; Destefanis G; Ladu S; Delogu S; Armbruster J; Fan L; Lee SA; Jiang L; Dombrowski F; Evert M; Chen X; Calvisi DF
    Hepatology; 2012 Mar; 55(3):833-45. PubMed ID: 21993994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T-Cells Infiltration and Immunosuppression.
    Luo X; Huang W; Li S; Sun M; Hu D; Jiang J; Zhang Z; Wang Y; Wang Y; Zhang J; Wu Z; Ji X; Liu D; Chen X; Zhang B; Liang H; Li Y; Liu B; Wang S; Xu X; Nie Y; Wu K; Fan D; Xia L
    Adv Sci (Weinh); 2024 Sep; 11(36):e2310304. PubMed ID: 39072947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
    Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K
    Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
    Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
    J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model.
    Li G; Liu D; Cooper TK; Kimchi ET; Qi X; Avella DM; Li N; Yang QX; Kester M; Rountree CB; Kaifi JT; Cole DJ; Rockey DC; Schell TD; Staveley-O'Carroll KF
    J Hepatol; 2017 Jan; 66(1):75-85. PubMed ID: 27520877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.
    Wiedemann GM; Röhrle N; Makeschin MC; Fesseler J; Endres S; Mayr D; Anz D
    Pathology; 2019 Oct; 51(6):586-592. PubMed ID: 31445808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.
    Langhans B; Nischalke HD; Krämer B; Dold L; Lutz P; Mohr R; Vogt A; Toma M; Eis-Hübinger AM; Nattermann J; Strassburg CP; Gonzalez-Carmona MA; Spengler U
    Cancer Immunol Immunother; 2019 Dec; 68(12):2055-2066. PubMed ID: 31724091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. YAP-1 Promotes Tregs Differentiation in Hepatocellular Carcinoma by Enhancing TGFBR2 Transcription.
    Fan Y; Gao Y; Rao J; Wang K; Zhang F; Zhang C
    Cell Physiol Biochem; 2017; 41(3):1189-1198. PubMed ID: 28472799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.
    Ke MY; Xu T; Fang Y; Ye YP; Li ZJ; Ren FG; Lu SY; Zhang XF; Wu RQ; Lv Y; Dong J
    Cancer Lett; 2021 Aug; 513():14-25. PubMed ID: 33992711
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
    Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus inhibits apoptosis of hepatoma cells by sponging the MicroRNA 15a/16 cluster.
    Liu N; Zhang J; Jiao T; Li Z; Peng J; Cui Z; Ye X
    J Virol; 2013 Dec; 87(24):13370-8. PubMed ID: 24089558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells.
    Wei R; Hu Y; Dong F; Xu X; Hu A; Gao G
    Immunol Cell Biol; 2016 Apr; 94(4):388-99. PubMed ID: 26639061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.
    Wu K; Kryczek I; Chen L; Zou W; Welling TH
    Cancer Res; 2009 Oct; 69(20):8067-75. PubMed ID: 19826049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.
    Zhou J; Ding T; Pan W; Zhu LY; Li L; Zheng L
    Int J Cancer; 2009 Oct; 125(7):1640-8. PubMed ID: 19569243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Feng X; Li B; Ye H; Long D
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.